Table 2 SF-36 baseline, follow-up and delta values and group differences

Physical functioning

85 (70–90)

88 (70–95)

0.0 (−8.3–10.0)

85 (70–94)

90 (80–95)

1.9 (−5.0–14.4)

0.58

Role physical

100 (75–100)

100 (100–100)

0.0 (0.0–25.0)

100 (75–100)

100 (75–100)

0.0 (−25.0–0.0)

0.15

Bodily pain

78 (75–100)

90 (58–100)

0.0 (−10.0–22.5)

78 (58–100)

79 (60–100)

0.0 (−12.5–20.0)

0.57

General health

70 (58–90)*

78 (65–85)

10.0 (−5.0–20.0)^†

80 (65–85)*

80 (70–90)

0.0 (−10.0–15.0)

0.26

Vitality

63 (50–85)

75 (65–85)

5.0 (−10.0–30.0)

75 (65–85)

75 (65–90)

0.0 (−10.0–10.0)

0.10

Social functioning

100 (88–100)

100 (100–100)

0.0 (0.0–12.5)

100 (100–100)

100 (100–100)

0.0 (−0.0–0.0)

0.22

Role emotional

100 (67–100)

100 (100–100)

0.0 (0.0–33.3)

100 (100–100)

100 (100–100)

0.0 (−0.0–0.0)

0.08

Mental health

80 (64–92)

88 (76–96)

4.0 (−8.0–28.0)

90 (72–96)

88 (72–92)

0.0 (−8.0–8.0)

0.17

PCS

80 (67–88)

86 (76–90)

3.8 (−1.9–19.5)^†

83 (73–90)

84 (69–92)

0.0 (−11.3–10.6)

0.12

MCS

84 (70–94)

90 (83–95)

4.4 (−2.4–23.3)^†

89 (83–94)

89 (78–94)

0.0 (−4.0–4.9)

0.03